Rivastigmine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151529This classification denotes an acetylcholinesterase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PKI06M3IW0. European Medicines Agency schedules Rivastigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10345MIG. Rivastigmine generally arises in the molecular formula C14H22N2O2. The term RIVASTIGMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 1 1998, list 39.) RIVASTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rivastigmine under HS 29242995 and SITC 51479. As of Q4 2014, RIVASTIGMINE remains the US FDA Preferred Term for this commodity. Rivastigmine bears US NLM identifiers UMLS ID C0649350 and NCI Concept Code C66519. SMILES: O(C1CC(C(N(C)C)C)CCC1)C(=O)N(CC)C.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.